Mindset | Jotup

Unexpected Release of One of the Best Motivational Books on Success: 'Success is a Mindset, not a Thought' by Michael K. Reed

Retrieved on:

Monday, April 25, 2022

Pressure, Xavier University of Louisiana, Success, HP, LLC, Adult, Twitter, Mindset, Xavier University, Human, Target, LinkedIn, Motivation, Lecture, Instagram, Lockheed, Interior design, Reed

He hopes that his work will empower others to be brave, bold, and confident in their own abilities.

Key Points:

He hopes that his work will empower others to be brave, bold, and confident in their own abilities.
Book cover of Success is a Mindset, not a Thought
Success is a Mindset, not a Thought blends anecdotes from Reed's past with down-to-earth recommendations for navigating volatile life circumstances.
Michael K. Reed is the founder of Shades of Greatness, LLC and the author of Success is a Mindset, not a Thought.
Reed graduated from Xavier University of Louisiana at the top of his class, and only took three years to do so.

Emerging Markets Report: More Tools in the Toolbox

Retrieved on:

Friday, April 22, 2022

ORLANDO, Fla., April 22, 2022 (GLOBE NEWSWIRE) -- Sometimes as we continue our coverage of Mindset Pharma Inc. (Mindset) (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) it feels as if we are covering TWO unique stories.

Key Points:

In an effort to build a toolbox that helps the most patients, Mindset continues to build out its patent portfolio.
If that happens, Mindset is already well down the road of putting tools in the toolbox.
About The Emerging Markets Report:
The Emerging Markets Report is owned and operated by Emerging Markets Consulting (EMC), a syndicate of investor relations consultants representing years of experience.
Our network consists of stockbrokers, investment bankers, fund managers, and institutions that actively seek opportunities in the micro and small-cap equity markets.

Mindset Pharma Strengthens IP Portfolio with Another New Provisional Patent Application Covering its Next-Generation DMT and 5-MeO-DMT Drug Candidate Compounds

Retrieved on:

Tuesday, April 19, 2022

CSE, Patent, Family, News, CEO, NCE, Drug discovery, GLOBE, MSET, Risk, Patient, Lists of diseases, FSE, DMT, Mental health, Company, THIS, Safety, THE, Pharmaceutical industry, Mindset, Development

In an effort to build a toolbox that helps the most patients, Mindset continues to build out its patent portfolio.

Key Points:

In an effort to build a toolbox that helps the most patients, Mindset continues to build out its patent portfolio.
The Mindset Family 4 compounds have shown promise in efficacy and safety at a range of doses compared to first-generation DMT and 5-MeO-DMT compounds based on rodent pre-clinical models.
Our strong IP position on this family enhances their commercial viability, said James Lanthier, CEO of Mindset.
Mindset is developing several novel families of next-generation psychedelic compounds, as well as an innovative process to chemically synthesize psilocybin in addition to its own proprietary compounds.

The Future is Bright: Millennials are Entering Motherhood with Control and Confidence, Prioritizing Self-Care and Maximizing Their Time

Retrieved on:

Wednesday, April 6, 2022

SEATTLE, April 6, 2022 /PRNewswire/ -- Whether for the first time or third, becoming a mom is an occasion full of emotion and excitement when the days can feel long but the years fly by. With more than 4 million babies being born each year, online retailer, Zulily, aims to make moms' lives easier and help maximize savings so she can stay focused on celebrating the little and big moments that come with a new family addition. This is exactly why Zulily is debuting its bi-annual Welcome Baby Event from April 6 – May 4 with the theme, "We Got You, Mama!" to help all new and expecting moms find the products and brands they need and want throughout their motherhood journey.

Key Points:

This is exactly why Zulily is debuting its bi-annual Welcome Baby Event from April 6 May 4 with the theme, "We Got You, Mama!"
to help all new and expecting moms find the products and brands they need and want throughout their motherhood journey.
Over 500 millennial moms across the country, both new and expectant, told Zulily that they are feeling more prepared and confident as they enter motherhood.
For more information, visit www.qurateretailgroup.com , or follow @QurateRetailGrp on Facebook , Instagram or Twitter , or followQurateRetail Group on YouTube or LinkedIn .

Mindset Pharma to Participate in Upcoming Conferences in April 2022

Retrieved on:

Tuesday, April 5, 2022

FSE, MSET, Conference, CEO, Otsuka Pharmaceutical, GLOBE, Drug discovery, Development, CSE, Pharmaceutical industry, Nightclub, Mindset

KCSA Psychedelics Investor Conference to be held virtually on April 27-28, 2022.

Key Points:

KCSA Psychedelics Investor Conference to be held virtually on April 27-28, 2022.
Mindset Pharma Inc. is a drug discovery and development company focused on creating optimized and patentable next-generation psychedelic medicines to treat neurological and psychiatric disorders with unmet needs.
Mindset was established in order to develop next-generation pharmaceutical assets that leverage the breakthrough therapeutic potential of psychedelic drugs.
For further information on Mindset, please visit our website at www.mindsetpharma.com .

Sage and The BOSS Network announce 35 awardees of the 2022 Sage Invest in Progress grants

Retrieved on:

Thursday, March 31, 2022

The goal of the BOSS Impact Fund is to raise investment funding for 500+ black women entrepreneurs over the next three years.

Key Points:

The goal of the BOSS Impact Fund is to raise investment funding for 500+ black women entrepreneurs over the next three years.
Initially scoped to award 25 grants, the overwhelming response of more than 12,500 applicants nationwide encouraged Sage and The BOSS Network to expand the program with 10 additional grants in the Sage Invest in Progress program.
These 35 awardees represent entrepreneurs from around the country and in various industries, including Beauty & Self-Care, Consumer Goods, Professional Services, Healthcare/Wellness, and Food and Beverage.
Each Sage Invest in Progress grant awardee receives:
Quarterly business training courses through BOSS University sponsored by Sage, focusing on Marketing, Finance, Customer Service, and Business Strategy
This is such an outstanding moment for The BOSS Network, said Cameka Smith, Founder and CEO of The BOSS Network.

Emerging Markets Report: Love Letters

Retrieved on:

Thursday, March 24, 2022

Company, Drug development, FSE, Letter, Therapy, Big Pharma, MSET, EMC, Emerging market, Mindset, Intention, GLOBE, Drug discovery, Consultant, Patient, CSE, Management, Pharmaceutical industry

ORLANDO, Fla., March 24, 2022 (GLOBE NEWSWIRE) -- In the world of emergent small cap companies there are a few things we love to see. Chief among them are positive shareholder letters from senior management.

Key Points:

Chief among them are positive shareholder letters from senior management.
As Lanthier eloquently calls it, a bridge from traditional Big Pharma to the new emerging world of psychedelic medicine.
About The Emerging Markets Report:
The Emerging Markets Report is owned and operated by Emerging Markets Consulting (EMC), a syndicate of investor relations consultants representing years of experience.
Our network consists of stockbrokers, investment bankers, fund managers, and institutions that actively seek opportunities in the micro and small-cap equity markets.

SynSaber Co-Founder and CTO Ron Fabela to Present at S4x22 Conference

Retrieved on:

Wednesday, March 30, 2022

Other Manufacturing, Technology, Security, Other Energy, Manufacturing, Software, Energy, Networks, Internet, Booth, RSA, CTO, ICS, Woman, Industry, Myth, Mindset, Risk management

SynSaber , an industrial asset and network monitoring company, today announced that co-founder, chief technology officer (CTO), and long-time industrial security expert Ron Fabela will be speaking on the main stage at S4x22, an operational technology/industrial control systems (OT/ICS) security conference taking place in Miami, FL April 19-21, 2022.

Key Points:

SynSaber , an industrial asset and network monitoring company, today announced that co-founder, chief technology officer (CTO), and long-time industrial security expert Ron Fabela will be speaking on the main stage at S4x22, an operational technology/industrial control systems (OT/ICS) security conference taking place in Miami, FL April 19-21, 2022.
SynSaber is a Featured Sponsor at this years event.
SynSaber founders will also be on hand at the event to discuss and demonstrate the companys recently announced 1.0 product release.
SynSaber is privately held with funding from SYN Ventures, Rally Ventures, and Cyber Mentor Fund.

Mindset Pharma CEO, James Lanthier, Issues Letter to Shareholders

Retrieved on:

Thursday, March 17, 2022

TORONTO, March 17, 2022 (GLOBE NEWSWIRE) -- Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) ("Mindset" or the "Company"), a drug discovery and development company focused on creating optimized and patentable next-generation psychedelic medicines to treat neurological and psychiatric disorders with unmet medical needs, today issued a letter to shareholders from James Lanthier, Chief Executive Officer of Mindset.

Key Points:

TORONTO, March 17, 2022 (GLOBE NEWSWIRE) -- Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) ("Mindset" or the "Company"), a drug discovery and development company focused on creating optimized and patentable next-generation psychedelic medicines to treat neurological and psychiatric disorders with unmet medical needs, today issued a letter to shareholders from James Lanthier, Chief Executive Officer of Mindset.
The partnership with MSRD is a major milestone, not only for Mindset but for the broader medical psychedelic industry.
This partnership represents a bridge from traditional big Pharma to the new emerging world of psychedelic medicine, which is an industry first.
This collaboration supports both Mindset and Otsukas mission to provide mental health solutions to a massive, underserved, population.

Finalists announced for mental health reporting awards

Retrieved on:

Tuesday, March 15, 2022

LONDON, ON, March 15, 2022 /CNW/ - The Canadian Journalism Forum on Violence and Trauma today announced the finalists for four awards for excellence in mental health reporting in Canada during 2021.

Key Points:

LONDON, ON, March 15, 2022 /CNW/ - The Canadian Journalism Forum on Violence and Trauma today announced the finalists for four awards for excellence in mental health reporting in Canada during 2021.
Awards for work in English are offered in the name of Mindset: Reporting on Mental Health and those in French in the name of its francophone counterpart En-Tte : reportage et sant mentale.
Each awards stream now has two categories, workplace mental health and the mental health of young people.
The workplace awards are sponsored by Workplace Strategies for Mental Health , compliments of Canada Life, while the new awards for reporting about young people's mental health are sponsored by the Canadian Mental Health Association .